Hutchinson Capital Managementca Exits Position in Monsanto Company (MON)

Monsanto Company (MON) : Hutchinson Capital Managementca has sold out all of its stake in Monsanto Company during the most recent quarter, according to the disclosure filed by the company on Aug 1, 2016 with the SEC. The investment management company has sold out 2,500 shares of Monsanto Company which is valued at $260,900.

Other Hedge Funds, Including , Mondrian Investment Partners Ltd boosted its stake in MON in the latest quarter, The investment management firm added 142,262 additional shares and now holds a total of 785,779 shares of Monsanto Company which is valued at $82,003,896. Monsanto Company makes up approx 1.94% of Mondrian Investment Partners Ltd’s portfolio.Public Employees Retirement Association Of Colorado reduced its stake in MON by selling 9,835 shares or 9.59% in the most recent quarter. The Hedge Fund company now holds 92,676 shares of MON which is valued at $9,895,017. Monsanto Company makes up approx 0.08% of Public Employees Retirement Association Of Colorado’s portfolio.Pennsylvania Trust Co reduced its stake in MON by selling 616 shares or 7.78% in the most recent quarter. The Hedge Fund company now holds 7,300 shares of MON which is valued at $779,348. Monsanto Company makes up approx 0.06% of Pennsylvania Trust Co’s portfolio.Hall Laurie J Trustee reduced its stake in MON by selling 1,400 shares or 82.35% in the most recent quarter. The Hedge Fund company now holds 300 shares of MON which is valued at $30,339. Monsanto Company makes up approx 0.02% of Hall Laurie J Trustee’s portfolio.

Monsanto Company opened for trading at $104.36 and hit $106.94 on the upside on Thursday, eventually ending the session at $106.42, with a gain of 1.97% or 2.06 points. The heightened volatility saw the trading volume jump to 49,51,389 shares. Company has a market cap of $46,567 M.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.